Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

Key takeaways for interventional cardiology from TCT 2025
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.
More good news for renal denervation: FDA-approved systems linked to positive long-term data
New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.
Evoque TTVR system linked to favorable outcomes in new real-world analysis
Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco.
First-in-human data highlight IVL’s potential to treat more challenging lesions
Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.
PARTNER 3 update: TAVR still comparable to SAVR in low-risk patients after 7 years
PARTNER 3 has been one of the most closely watched clinical trials in cardiology for many years now. Michael J. Mack, MD, presented a seven-year update during a packed session at TCT 2025.

RSNA21: Deep learning automatically labels coronary arteries to produce structured CCTA reports

The algorithm yielded a 94.4% accuracy for labeling arteries in accordance with the Society of Cardiovascular Computed Tomography guidelines.

Stem cell therapy for heart failure lowers risk of adverse outcomes

“Cell therapy has the potential to change how we treat heart failure,” one researcher said.

Cardiologs puts its AI model up against the Apple Watch—and wins

The company reported that its deep neural network led to improved sensitivity and fewer unclassified findings.

European Society of Cardiology shares new guidance on COVID-related cardiovascular disease

The two-part document was published in full in European Heart Journal.

High-dose icosapent ethyl treatment makes minimal impact on non-hospitalized COVID-19 patients

The analysis, presented at AHA Scientific Sessions 2021, included approximately 2,000 symptomatic COVID-19 patients who were not necessarily sick enough to be hospitalized.

American Heart Association responds to nomination of cardiologist Robert Califf for FDA commissioner

The AHA believes the next FDA commissioner should play a key role in influencing public health post-COVID-19.

New research details how drug and alcohol use increases a person's AFib risk

The findings, to be presented at AHA Scientific Sessions 2021, focused on methamphetamines, opiates, cocaine, cannabis and alcohol.

Eating the right kind of fats can reduce a person's stroke risk

The new findings are from research to be presented at AHA Scientific Sessions 2021.

Cardiology Associations

Key takeaways for interventional cardiology from TCT 2025

More good news for renal denervation: FDA-approved systems linked to positive long-term data

Evoque TTVR system linked to favorable outcomes in new real-world analysis

First-in-human data highlight IVL’s potential to treat more challenging lesions

PARTNER 3 update: TAVR still comparable to SAVR in low-risk patients after 7 years